$3.52
0[0.00%]
At close: Apr 29
$3.52
0[0.00%]
PreMarket: 4:00PM EDT
Sutro Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sutro Biopharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/13/2024 | AM | STRO | Q1 | -$0.85 | -$0.86 | — | — | $12.67M | $11.97M | — | — | Get Alert |
03/25/2024 | PM | STRO | Q4 | -$0.61 | -$0.82 | $0.52 | 163.41% | $8.63M | $11.81M | $113.72M | 862.92% | Get Alert |
11/13/2023 | PM | STRO | Q3 | -$0.37 | -$0.74 | -$0.81 | -9.46% | $25.15M | $12.61M | $16.92M | 34.21% | Get Alert |
08/10/2023 | PM | STRO | Q2 | -$0.55 | -$0.73 | -$0.64 | 12.33% | $28.10M | $12.56M | $10.41M | -17.10% | Get Alert |
05/15/2023 | AM | STRO | Q1 | -$0.84 | -$0.81 | -$0.85 | -4.94% | $5.90M | $11.14M | $12.67M | 13.77% | Get Alert |
03/30/2023 | PM | STRO | Q4 | -$0.83 | -$0.62 | -$0.61 | 1.61% | $10.65M | $14.48M | $8.63M | -40.39% | Get Alert |
11/08/2022 | PM | STRO | Q3 | -$0.67 | -$0.74 | -$0.37 | 50.00% | $8.52M | $12.68M | $25.15M | 98.32% | Get Alert |
08/08/2022 | PM | STRO | Q2 | -$0.13 | -$0.46 | -$0.55 | -19.57% | $28.05M | $16.69M | $28.10M | 68.34% | Get Alert |
05/09/2022 | PM | STRO | Q1 | -$0.66 | -$0.76 | -$0.84 | -10.53% | $14.66M | $10.47M | $5.90M | -43.68% | Get Alert |
02/28/2022 | PM | STRO | Q4 | -$1.48 | -$0.69 | -$0.83 | -20.29% | $8.28M | $10.65M | $10.65M | 0.04% | Get Alert |
11/10/2021 | AM | STRO | Q3 | $0.45 | -$0.65 | -$0.67 | -3.08% | $17.82M | $8.97M | $8.52M | -5.05% | Get Alert |
08/09/2021 | AM | STRO | Q2 | -$0.60 | -$0.41 | -$0.13 | 68.29% | $9.47M | $13.34M | $28.05M | 110.26% | Get Alert |
05/07/2021 | AM | STRO | Q1 | -$0.84 | -$0.48 | -$0.66 | -37.50% | $7.15M | $10.57M | $14.66M | 38.69% | Get Alert |
03/18/2021 | PM | STRO | Q4 | -$0.65 | — | -$1.48 | — | $11.30M | — | $8.28M | — | Get Alert |
11/05/2020 | AM | STRO | Q3 | -$0.56 | — | $0.45 | — | $12.28M | — | $17.82M | — | Get Alert |
08/06/2020 | AM | STRO | Q2 | -$0.60 | -$0.64 | -$0.60 | 6.25% | $10.53M | $7.97M | $9.47M | 18.81% | Get Alert |
05/11/2020 | PM | STRO | Q1 | -$0.62 | — | -$0.84 | — | $8.63M | — | $7.15M | — | Get Alert |
03/16/2020 | AM | STRO | Q4 | -$0.07 | -$0.69 | -$0.65 | 5.80% | $19.09M | $9.96M | $11.30M | 13.50% | Get Alert |
11/08/2019 | AM | STRO | Q3 | -$21.26 | — | -$0.56 | — | $7.84M | — | $12.28M | — | Get Alert |
Sutro Biopharma (STRO) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on March 25, 2024 for Q4.
The Actual EPS was $0.52, which beat the estimate of $-0.82.
The Actual Revenue was $113.7M, which beat the estimate of $11.8M.
Browse earnings estimates, EPS, and revenue on all stocks.